Industry reaction to a new law that makes changes to the Clinical Laboratory Fee Schedule (CLFS) appears to be split, with some laboratory groups applauding the changes and others concerned that it places hospital labs and regional and community labs at a disadvantage. The Protecting Access to Medicare Act of 2014, signed into law in…

This content is for Paid Members only.
Login Register